[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346480-105":59,"doc-detail-346480-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-potential-of-mmp14-as-a-prognostic-and-immune-biomarker-in-lung-cancer","The potential of MMP14 as a prognostic and immune biomarker in lung cancer","","Precision therapy and prognostic assessment are critical for improving quality of life in lung cancer. While NSUN2-mediated m5C RNA methylation is implicated in multiple malignancies, the downstream role of its target MMP14 in lung adenocarcinoma remains unclear. Using NSUN2 knockdown in A549 cells, RNA-seq, and RT-qPCR validation, combined with TCGA and multi-database integrated analysis, the study clarifies regulatory mechanisms and clinical value in LUAD.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-potential-of-mmp14-as-a-prognostic-and-immune-biomarker-in-lung-cancer/346480/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-potential-of-mmp14-as-a-prognostic-and-immune-biomarker-in-lung-cancer/346480.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research focus of the study?","Question",{"text":112,"@type":113},"The study evaluates whether MMP14 can serve as a prognostic and immune biomarker in lung cancer, particularly in lung adenocarcinoma (LUAD), and examines its regulation by NSUN2-mediated m5C RNA methylation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was MMP14 investigated experimentally?",{"text":117,"@type":113},"A549 cells were used to establish a stable NSUN2 knockdown model. Differentially expressed MMP14 was identified via RNA-seq and validated using RT-qPCR, followed by integrated analysis with TCGA and multiple databases.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical and immune-related associations were found for MMP14?",{"text":121,"@type":113},"MMP14 is overexpressed in LUAD and other malignancies, with elevated levels linked to poor prognosis and advanced tumor stage. In LUAD, MMP14 correlates with immune cell infiltration (including macrophages and T cells) and immune checkpoint molecules such as PD-1 and PD-L1.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346480,1790196421,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Xiao et al. BMC Cancer (2026) 26:256 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-15539-1](https://doi.org/10.1186/s12885-025-15539-1)  \nRESEARCH Open Access  \nThe potential of MMP14 as a prognostic and immune biomarker in lung cancer  \nJiajia Xiao1†, Zhenpeng Zhu1,4†, Fan Zhang3 and Xinsheng Wang2*  \nAbstract  \nBackground Precision therapy and prognostic assessment are crucial for improving the quality of life of patients with lung cancer. While NSUN2-mediated m⁵C RNA methylation is involved in multiple malignancies, the role of its downstream target MMP14 in lung adenocarcinoma remains undefined.  \nMethods Using the A549 cell line as the research object, we established a stable NSUN2 knockdown model. Differentially expressed gene MMP14 was identified through RNA-seq, and its expression was validated by quantitative real-time polymerase chain reaction (RT-qPCR) . Combined with The Cancer Genome Atlas (TCGA) and multi-database integrated analysis, we thoroughly elucidated the molecular regulatory mechanisms (focusing on RNA methylation-related pathways) and clinical value of MMP14 in LUAD.  \nResults Our findings demonstrate that MMP14 is overexpressed in LUAD and multiple other malignancies, and that its elevated expression is significantly associated with poor prognosis and advanced tumor stage. In LUAD, MMP14 RNA methylation levels are positively correlated with mRNA expression, while DNA promoter methylationis closely linked to tumor progression and lymph node metastasis. MMP14 expression is regulated by NSUN2, a key m⁵C methyltransferase, and functionally participates in diverse tumor-associated biological processes. Notably, MMP14 expression correlates with immune cell infiltration, including macrophages and T cells, as well as with immune checkpoint molecules such as PD-1 and PD-L1, highlighting its potential role in shaping the tumor immune microenvironment.  \nConclusion MMP14, a key NSUN2-regulated molecule in LUAD, represents a potential target for precision diagnosis and therapy and may provide new insights into improving overall survival in LUAD.  \nKeywords RNA-seq, NSUN2, MMP14, Lung adenocarcinoma, Methylation, Single-cell sequencing, Tumor heterogeneity, Prognostic assessment  \n†Jiajia Xiao and Zhenpeng Zhu contributed equally to this work.  \n*Correspondence:  \nXinsheng Wang  \n[wangxinsheng@hbbfyfy.com](wangxinsheng@hbbfyfy.com)  \n1Hebei North University, Zhangjiakou, Hebei Province 075000, China 2Hebei Key Laboratory of Pathogenic Mechanisms and Diagnosis & Treatment Technologies for Lung Microbiome, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei Province 075000, China 3Department of Pathology, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei Province 075000, China  \n4Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250000, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0","cbCaiqegmQDqke2L","https://ap.wps.com/l/cbCaiqegmQDqke2L","pdf",14099426,24,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main research focus of the study?\",\"answer\":\"The study evaluates whether MMP14 can serve as a prognostic and immune biomarker in lung cancer, particularly in lung adenocarcinoma (LUAD), and examines its regulation by NSUN2-mediated m5C RNA methylation.\"},{\"question\":\"How was MMP14 investigated experimentally?\",\"answer\":\"A549 cells were used to establish a stable NSUN2 knockdown model. Differentially expressed MMP14 was identified via RNA-seq and validated using RT-qPCR, followed by integrated analysis with TCGA and multiple databases.\"},{\"question\":\"What clinical and immune-related associations were found for MMP14?\",\"answer\":\"MMP14 is overexpressed in LUAD and other malignancies, with elevated levels linked to poor prognosis and advanced tumor stage. In LUAD, MMP14 correlates with immune cell infiltration (including macrophages and T cells) and immune checkpoint molecules such as PD-1 and PD-L1.\"}]","The potential of MMP14 as a prognostic and immune biomarker in lung cancer | PDF",1790061630,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84b3a58784e315c4cd4c977c809c4b95.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8865344ef31a870b216ffb290bda3e55.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec0eb94e0db5bbb36952b5e61d09b2f7.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bc7f8d5a26e56f17b16dfba54d5e81d.webp",980,1306]